Fresenius Medical Care (FMS.US) will release its Earnings Reports before the market opens on May 6.
$Fresenius Medical Care (FMS.US)$ will release its Earnings Reports before the market opens on May 6, and investors are advised to pay attention. How was the previous performance? $Fresenius Medical Care (FMS.US)$ had a revenue of 5.085 billion euros and a Net income of 0.119 billion euros for Q4 2024, with an EPS of 0.12 euros. In Q1 2024, the revenue was 4.725 billion euros, the Net income was 0.118 billion euros, and the EPS was 0.12 euros. The accounting standards used for the above data are US_GAAP. Futubull reminds: 1. There are no strict regulations regarding the fiscal year division for companies listed on the Hong Kong and U.S. stock markets; it is completely up to...
Berenberg Sees 'Solid' Q1 for Fresenius, Affirms Buy Rating Ahead of Q1 Results
Top Gap Ups and Downs on Monday: SAP, TM, MUFG and More
Fresenius Medical Care (ETR:FME) Will Be Hoping To Turn Its Returns On Capital Around
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence
Berenberg Keeps Fresenius Medical at Buy on Expected Buffer Against Tariffs
Analysts Offer Insights on Healthcare Companies: Fresenius Medical Care (FMS), Merck & Company (MRK) and Insmed (INSM)
Why Fresenius Medical Care Stock Might Be a Great Pick
Bernstein Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
DaVita Comes Under Ransomware Attack
6-K: Report of foreign private issuer (related to financial reporting)
Fresenius Medical Care (ETR:FME) Is Paying Out A Larger Dividend Than Last Year
Fresenius Medical Care Completes Bond Tender Offer With Increased Acceptance
Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now?
Top Gap Ups and Downs on Thursday: UL, SHOP, NKE and More
Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday
Is Fresenius Medical Care (FMS) the Best German Stock to Buy According to Hedge Funds?
Fresenius Medical Care Secures €1.1 Billion Through Bond Issuance
Trump's Medical Tariffs Could Significantly Hurt These European Healthcare Firms
Express News | Fresenius Medical Care Capital Trust V - FDA Approval for Their Denosumab Biosimilars and Secures Global Settlement Agreement